703 related articles for article (PubMed ID: 24872110)
21. Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats.
Samuelson E; Hedberg C; Nilsson S; Behboudi A
Endocr Relat Cancer; 2009 Mar; 16(1):99-111. PubMed ID: 19075038
[TBL] [Abstract][Full Text] [Related]
22. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification.
Ordi J; Bergeron C; Hardisson D; McCluggage WG; Hollema H; Felix A; Soslow RA; Oliva E; Tavassoli FA; Alvarado-Cabrero I; Wells M; Nogales FF
Histopathology; 2014 Jan; 64(2):284-92. PubMed ID: 24111732
[TBL] [Abstract][Full Text] [Related]
24. A new perspective on Endometrial Carcinoma classification and management strategies in context of molecular subtypes.
Ballová Z; Gašparová P; Sitáš M; Dosedla E
Ceska Gynekol; 2024; 89(2):128-132. PubMed ID: 38704225
[TBL] [Abstract][Full Text] [Related]
25. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.
Oda K; Stokoe D; Taketani Y; McCormick F
Cancer Res; 2005 Dec; 65(23):10669-73. PubMed ID: 16322209
[TBL] [Abstract][Full Text] [Related]
26. Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer.
Yamaguchi T; Kawahara A; Hattori S; Taira T; Abe H; Sanada S; Akiba J; Nishio S; Ushijima K; Kamura T; Kage M
Cytopathology; 2015 Jun; 26(3):157-66. PubMed ID: 24827996
[TBL] [Abstract][Full Text] [Related]
27. Bokhman Redux: Endometrial cancer "types" in the 21st century.
Suarez AA; Felix AS; Cohn DE
Gynecol Oncol; 2017 Feb; 144(2):243-249. PubMed ID: 27993480
[TBL] [Abstract][Full Text] [Related]
28. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
29. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X
Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921
[TBL] [Abstract][Full Text] [Related]
30. [Topics on gene abnormality in endometrial cancer].
Shiozawa T; Konishi I
Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
[No Abstract] [Full Text] [Related]
31. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
32. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
Xu B; Yao Q; Dai SZ
Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
[TBL] [Abstract][Full Text] [Related]
33. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
[TBL] [Abstract][Full Text] [Related]
34. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
[TBL] [Abstract][Full Text] [Related]
35. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
Horn LC; Meinel A; Handzel R; Einenkel J
Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway.
Murayama-Hosokawa S; Oda K; Nakagawa S; Ishikawa S; Yamamoto S; Shoji K; Ikeda Y; Uehara Y; Fukayama M; McCormick F; Yano T; Taketani Y; Aburatani H
Oncogene; 2010 Apr; 29(13):1897-908. PubMed ID: 20062086
[TBL] [Abstract][Full Text] [Related]
37. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma.
Shih IeM; Wang TL
J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855
[TBL] [Abstract][Full Text] [Related]
38. Molecular alterations in endometrial archived liquid-based cytology.
Di Lorito A; Rosini S; Falò E; Gustapane S; Gomes M; Costa JL; Schmitt FC
Diagn Cytopathol; 2013 Jun; 41(6):492-6. PubMed ID: 22807394
[TBL] [Abstract][Full Text] [Related]
39. New staging of endometrial carcinoma - FIGO 2023.
Hruda M; Sehnal B; Halaška MJ; Drozenová J; Robová H; Pichlík T; Rob L
Ceska Gynekol; 2024; 89(2):120-127. PubMed ID: 38704224
[TBL] [Abstract][Full Text] [Related]
40. [Molecular mechanisms in endometrial carcinoma].
Nakao Y; Iwasaka T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():248-53. PubMed ID: 15535245
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]